Skip to main content
Premium Trial:

Request an Annual Quote

The “Futurology” of Biopharma

Deepak Singh writes about a report commissioned by British Telecom, which examines the future of the biopharma industry. The core argument of the report, writes Singh at business|bytes|genes|molecules, is that the industry needs to change “by becoming one part of the healthcare ecosystem, one driven by communication technologies and the increased digitization of patient information.” He tackles some key features of the report, called “Pharma Futurology: Joined-up healthcare, 2016 and beyond,” including whether drug development based on in silico models is really only a decade away, the need for physicians to redefine their roles, and in what form personalized medicine will actually materialize.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.